Corvus Pharmaceuticals Inc (CRVS)
$10.03 -1.96% Close Oct 30, 2026 Live
Corvus Pharmaceuticals stock today
Corvus Pharmaceuticals closed at $10.03 on October 30, 2026, down 1.96% on the day. Over the past year it returned +29.3% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $843 million.
$10.00$20.00
NovJan 2026MarMayJulSep
| Period | CRVS | S&P 500 (SPY) |
|---|---|---|
| 1 month | -12.9% | -0.9% |
| 3 months | -24.0% | +2.1% |
| Year to date | +30.3% | +11.7% |
| 1 year | +29.3% | +12.4% |
| 3 years | +828.7% | +88.5% |
| 5 years | +121.4% | +76.0% |
Key statistics
- Market value
- $843M
- 52-week range
- $6.50 to $25.52
- Next report
- Nov 5, 2026
About Corvus Pharmaceuticals
Biopharmaceutical company developing oncology and immunology drug candidates.
Sector: Health Care
More on Corvus Pharmaceuticals
- Returns: what $1,000 became$1,000 ten years ago is $735.88 today
No forecast, no recommendation. This page describes Corvus Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.